Power·to·Practice
Our Portfolio

A deliberately narrow
portfolio of devices.

Three platforms covering the indications that drive the majority of revenue in a modern Australian aesthetic clinic — plus a practitioner-only therapeutic-goods range.

GENOSS
MonaLisa · PN · 2.0 mL
REF 30
GENOSSRx
MONAL)SA
Skin-Needling Serum · PN
PN
30 mg / mL
Sterile · Single Use2.0 mL × 1
LOT 240412AEXP 2027.04
Topical Skin-Needling Serum

MonaLisa PN 30

Long-chain salmon polynucleotide at 30 mg/mL. One active. Undiluted.

Product Details
GENOSS
MonaLisa · PH · 2.0 mL
PN + HA
GENOSSRx
MONAL)SA
Skin-Needling Serum · PH
PH
DOUBLE
PN 20 mg/mL · HA 10 mg/mL
Sterile · Single Use2.0 mL × 1
LOT 240412CEXP 2027.04
Topical PN + HA Skin-Needling Serum

MonaLisa PH

Double booster — polynucleotide + cross-stabilised hyaluronic acid in one syringe.

Product Details
Octave Platform
8-in-1 Aesthetic Platform · by Apolomed

Octave Platform

IPL, EPL, Nd:YAG, Er:Glass, Er:YAG and RF in a single console.

Product Details
Practitioner Access Required

HCP-Only Therapeutic Goods

Information about prescription-only therapeutic goods we distribute is restricted to verified Australian healthcare practitioners under the Therapeutic Goods Advertising Code.

Verify HCP Access

Devices in the Power to Practice portfolio are supplied to Australian healthcare practitioners. Skin-needling serums are manufactured by GENOSS in Seoul, South Korea. Therapeutic-good product information is restricted to verified practitioners under the Therapeutic Goods Advertising Code — refer to each product page for further details.